There is a noteworthy update this afternoon in the long-running effort to turn cells from healthy donors into effective cancer treatments — data suggesting an experimental therapy from Allogene Therapeutics may help very sick patients with non-Hodgkin lymphoma.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,